OFEV
As listed in the register: OFEV
150 mg · capsule
- Prescription only
- Cancer treatments and immune-system medicines
- Active substance
- Nintedanib (Nintedanib Esilate)
- Made by
- Boehringer Ingelheim (Canada) Ltd Ltee
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
European UnionNo exact match for this strength and form
Spain16 matching products
- NINTEDANIB ACCORD 150 mg · cápsula blanda
- NINTEDANIB ACCORDPHARMA 150 mg · cápsula blanda
- NINTEDANIB CINFA 150 mg · cápsula blanda
- NINTEDANIB CIPLA 150 mg · cápsula blanda
- NINTEDANIB DR.REDDYS 150 mg · cápsula blanda
- NINTEDANIB EUGIA 150 mg · cápsula blanda
- NINTEDANIB GLENMARK 150 mg · cápsula blanda
- NINTEDANIB INTAS 150 mg · cápsula blanda
Netherlands21 matching products
- Nintedanib Teva 150 mg 150 mg · capsule, zacht2 makers
- Gevesla 150 mg 150 mg · capsule, zacht
- Nintedanib 1A Pharma 150 mg 150 mg · capsule, zacht
- Nintedanib Accord 150 mg zachte capsules 150 mg · capsule, zacht
- Nintedanib CF 150 mg 150 mg · capsule, zacht
- Nintedanib Cipla 150 mg 150 mg · capsule, zacht
- Nintedanib Devatis 150 mg 150 mg · capsule, zacht
- Nintedanib Eugia 150 mg 150 mg · capsule, zacht
SwitzerlandNo exact match for this strength and form
Details
| Made by | Boehringer Ingelheim (Canada) Ltd Ltee |
|---|---|
| Active substance | Nintedanib (Nintedanib Esilate) |
| Used in | Cancer treatments and immune-system medicines |
| Strength | 150 mg |
| Form | capsule |
| Classification | L01EX09 · Cancer treatments and immune-system medicines |
| Route | oral |
| Dispensing (as stated by the register) | PRESCRIPTION |
| Status | Marketed |
| Marketed | Yes, according to the register |
| DIN | 02443074 |
| DPD drug code | 92761 |
Source: Drug Product Database · 2026-09-30 · not reviewed by a clinician
Contains information licensed under the Open Government Licence – Canada. Reuse terms: Open Government Licence – Canada.
Other strengths and forms
2 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
- capsule2 products
- 100 mg
- 150 mg
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.